HOME › DRUGS › VALOCTOCOGENE ROXAPARVOVEC
ACTIVE SUBSTANCE / INN

VALOCTOCOGENE ROXAPARVOVEC

Brand name(s): Roctavian
EMA LISTED
APPLICATION WITHDRAWN
AUTHORISED
Hemophilia A
ACTIVE SUBSTANCE
Valoctocogene Roxaparvovec
REGULATORS
EMA
SPONSORS / MAH
BioMarin International Limited
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
RoctavianBioMarin International LimitedAuthorised24/08/2022—
RoctavianBioMarin International LimitedApplication withdrawnHemophilia A

FULL INTELLIGENCE ON VALOCTOCOGENE ROXAPARVOVEC

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →